Suture fixation of a posterior chamber intraocular lens in anticoagulated patients.
OBJECTIVE
To describe a technique of suture fixating posterior chamber silicone intraocular lenses (PC IOLs) to the iris through a limbal incision and to evaluate its effectiveness in preventing intraocular hemorrhages.


METHODS
Price Vision Group, Indianapolis, Indiana, USA.


METHODS
This retrospective single-center study comprised 7 eyes (5 patients) that had suture fixation of a silicone PC IOL from a limbal approach to the midperipheral iris using 9-0 polypropylene (Prolene(R)) suture. All patients were taking warfarin sodium (Coumadin(R)) preoperatively and postoperatively. At each follow-up examination, visual acuity and intraocular pressure were measured, the stability of the PC IOL was assessed, and the anterior chamber and posterior segment were evaluated for blood.


RESULTS
There was no incidence of intraocular hemorrhage during surgery in any eye. In 6 eyes, there was no blood in the anterior chamber or posterior segment at any postoperative examination. A nonlayering hyphema that resolved within 1 week without sequelae was noted in 1 patient 6 weeks postoperatively. The mean follow-up was 10.7 months (range 6 to 25 months).


CONCLUSIONS
Suture fixating a PC IOL to the iris through a limbal approach was an effective means of placing an IOL in anticoagulated patients without capsule support.
Parker
D Shawn
DS
Eye Care Specialists, Cape Girardeau, Missouri, USA.
Price
Francis W
FW
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage*; D001672:Biocompatible Materials; D006801:Humans; D006988:Hyphema / Q000517:prevention & control; D007429:Intraocular Pressure; D007498:Iris / Q000601:surgery*; D019654:Lens Implantation, Intraocular / Q000379:methods*; D007910:Lenses, Intraocular; D008875:Middle Aged; D011126:Polypropylenes; D012189:Retrospective Studies; D012826:Silicone Elastomers; D013536:Suture Techniques; D013537:Sutures; D014792:Visual Acuity; D014823:Vitreous Hemorrhage / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage*
D000925:Anticoagulants; D001672:Biocompatible Materials; D011126:Polypropylenes; D012826:Silicone Elastomers; D014859:Warfarin